CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
145 hedge funds and large institutions have $620M invested in CTI BioPharma Corp. (DE) Common Stock in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 48 increasing their positions, 37 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 133 → 145 (+12)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
145
Holding in Top 10
4
Calls
$14.5M
Puts
$471K
Top Buyers
| 1 | +$22.7M | |
| 2 | +$13.6M | |
| 3 | +$9.92M | |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$8.45M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$5.97M |
Top Sellers
| 1 | -$9.51M | |
| 2 | -$9.2M | |
| 3 | -$4.42M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$4.38M |
| 5 |
PA
Perceptive Advisors
New York
|
-$4.28M |